O

Ocular Therapeutix
D

OCUL

9.61000
USD
0.17
(1.75%)
مغلق
حجم التداول
48,197
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
1,530,870,463
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
A
ACAD
-0.285
(-1.34%)
20.955 USD
A
AVDL
0.13500
(1.54%)
8.93000 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
JNJ
JNJ
0.570
(0.37%)
156.110 USD
REGN
REGN
-0.69
(-0.13%)
546.88 USD
المزيد
الأخبار المقالات

العنوان: Ocular Therapeutix

القطاع: Healthcare
الصناعة: Biotechnology
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.